Dec 19, 2024 8:30am EST Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
Dec 09, 2024 8:30am EST Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
Dec 02, 2024 8:30am EST Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
Nov 12, 2024 9:00am EST Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
Sep 13, 2021 11:00am EDT Gelteq Granted First U.S. Patent for Gel-based Blood Glucose Testing Product and Methodology